Literature DB >> 21798577

Predisposition to the development of IL-9-secreting T cells in atopic infants.

Weiguo Yao, Robert S Tepper, Mark H Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21798577      PMCID： PMC3208121          DOI： 10.1016/j.jaci.2011.06.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children.

Authors:  M C Jenmalm; J Van Snick; F Cormont; B Salman
Journal:  Clin Exp Allergy       Date:  2001-10       Impact factor: 5.018

2.  Increased expression of interleukin-9 messenger RNA after segmental allergen challenge in allergic asthmatics.

Authors:  Veit J Erpenbeck; Jens M Hohlfeld; Marc Discher; Harald Krentel; Andreas Hagenberg; Armin Braun; Norbert Krug
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

3.  Allergen-induced interleukin-9 production in vitro: correlation with atopy in human adults and comparison with interleukin-5 and interleukin-13.

Authors:  S Devos; F Cormont; S Vrtala; E Hooghe-Peters; F Pirson; J Snick
Journal:  Clin Exp Allergy       Date:  2006-02       Impact factor: 5.018

4.  Evaluation of airway reactivity and immune characteristics as risk factors for wheezing early in life.

Authors:  Weiguo Yao; Florencia M Barbé-Tuana; Conrado J Llapur; Marcus H Jones; Christina Tiller; Risa Kimmel; Jeffrey Kisling; Evelyn T Nguyen; James Nguyen; Zhangsheng Yu; Mark H Kaplan; Robert S Tepper
Journal:  J Allergy Clin Immunol       Date:  2010-09       Impact factor: 10.793

Review 5.  A brief history of IL-9.

Authors:  Ritobrata Goswami; Mark H Kaplan
Journal:  J Immunol       Date:  2011-03-15       Impact factor: 5.422

6.  Expired nitric oxide and airway reactivity in infants at risk for asthma.

Authors:  Robert S Tepper; Conrado J Llapur; Marcus H Jones; Christina Tiller; Cathy Coates; Risa Kimmel; Jeffrey Kisling; Barry Katz; Yan Ding; Nancy Swigonski
Journal:  J Allergy Clin Immunol       Date:  2008-08-28       Impact factor: 10.793

7.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

8.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

9.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606
  9 in total
  31 in total

Review 1.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

2.  Stimulation of histamine H4 receptors increases the production of IL-9 in Th9 polarized cells.

Authors:  Katrin Schaper-Gerhardt; Mareike Wohlert; Susanne Mommert; Manfred Kietzmann; Thomas Werfel; Ralf Gutzmer
Journal:  Br J Pharmacol       Date:  2019-02-21       Impact factor: 8.739

Review 3.  The symphony of the ninth: the development and function of Th9 cells.

Authors:  Rukhsana Jabeen; Mark H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-02-22       Impact factor: 7.486

Review 4.  Th9 and other IL-9-producing cells in allergic asthma.

Authors:  Sonja Koch; Nina Sopel; Susetta Finotto
Journal:  Semin Immunopathol       Date:  2016-11-17       Impact factor: 9.623

Review 5.  Genetic evidence for the role of transforming growth factor-β in atopic phenotypes.

Authors:  Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Immunol       Date:  2019-06-01       Impact factor: 7.486

6.  Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.

Authors:  Christoph Schlapbach; Ahmed Gehad; Chao Yang; Rei Watanabe; Emmanuella Guenova; Jessica E Teague; Laura Campbell; Nikhil Yawalkar; Thomas S Kupper; Rachael A Clark
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

7.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP.

Authors:  Weiguo Yao; Yanlu Zhang; Rukhsana Jabeen; Evelyn T Nguyen; David S Wilkes; Robert S Tepper; Mark H Kaplan; Baohua Zhou
Journal:  Immunity       Date:  2013-01-31       Impact factor: 31.745

Review 9.  Th9 cells: differentiation and disease.

Authors:  Mark H Kaplan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

10.  IL-4-, TGF-β-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic filariasis.

Authors:  Rajamanickam Anuradha; Parakkal Jovvian George; Luke E Hanna; Vedachalam Chandrasekaran; Paul Kumaran; Thomas B Nutman; Subash Babu
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.